WO2013105693A1 - Composition pharmaceutique comprenant un extrait de cortex d'oryza sativa l. et d'hordeum vulgare var. hexastichon comme principe actif - Google Patents

Composition pharmaceutique comprenant un extrait de cortex d'oryza sativa l. et d'hordeum vulgare var. hexastichon comme principe actif Download PDF

Info

Publication number
WO2013105693A1
WO2013105693A1 PCT/KR2012/001263 KR2012001263W WO2013105693A1 WO 2013105693 A1 WO2013105693 A1 WO 2013105693A1 KR 2012001263 W KR2012001263 W KR 2012001263W WO 2013105693 A1 WO2013105693 A1 WO 2013105693A1
Authority
WO
WIPO (PCT)
Prior art keywords
extract
husk
barley
rice
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2012/001263
Other languages
English (en)
Korean (ko)
Inventor
이용규
모하메드너루나비
모하메드라마둘라
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Korea National University of Transportation KNUT
Original Assignee
Korea National University of Transportation KNUT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korea National University of Transportation KNUT filed Critical Korea National University of Transportation KNUT
Publication of WO2013105693A1 publication Critical patent/WO2013105693A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A61K36/8998—Hordeum (barley)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Definitions

  • the present invention relates to a pharmaceutical composition
  • a pharmaceutical composition comprising a rice hull and barley husk extract as an active ingredient, and more particularly, in the treatment of poultry, fish and livestock exposed to diseases caused by a number of pathogens such as viruses and bacteria. It relates to an effective pharmaceutical composition.
  • Plants have long been a source of various natural substances that help human well-being, and in particular the leaves, bark and roots of some specific plants have been used to treat a variety of diseases and infections. There are thousands of plants that are widely used for therapeutic purposes in developing countries as well as in developed countries.
  • Primary plant metabolites are universally present in the plant population and comprise most of the chemicals produced by plants, but other compounds are classified as secondary metabolites and are the focal point of both scientific research and commercial use because of their many uses. Has become.
  • rice (Oryza sativa L.) is an annual herb, although there are many types of rice but not fresh ( ⁇ ) Depending on the viscosity of the), it is divided into types of rice, field rice, and waxy rice. Rice contains about 75% starch, about 8% gray matter, and about 0.5% to 1% fat. In addition, it contains a small amount of vitamin B. The vitamin content varies depending on the type of rice and the plantation. Fatty parts include ester and free cholesterol, brassicasterol, stigmasterol, sitosterol, monoglycerides, diglycerides, triglycerides, phospholipids, Free fatty acids and the like. Its pharmacological effects include Bojungikgi ( ⁇ ), Jebungal ( ⁇ ⁇ ), Jisari ( ⁇ ⁇ ) efficacy.
  • Barley (Hordeum vulgare var. Hexastichon) is one of the major cultivated crops, which is known to be good for hangovers.For prevention and treatment of hangovers, brown barley common barley is selected, and whole barley or barley mixed with barley is always recommended. Shin Jae-yong, consent folk remedies, 116-117). Barley contains polyphenolic substances, and these compounds are more contained in the outer layer and embryonic part containing the bark than the inner endosperm of barley, and the barley extract has high antioxidant and active oxygen scavenging ability. Reported. In addition, barley is known to be effective in suppressing cholesterol, diabetes, heart disease, and the like.
  • the present invention is effective to extract rice hull and barley husk extract effective for the treatment and prevention of poultry, fish and livestock exposed to diseases caused by a number of pathogens such as viruses, bacteria, etc. It is an object to provide a pharmaceutical composition comprising as a component.
  • the present invention has an immune enhancing effect, can be used as a cholesterol lowering agent by reducing the amount of total cholesterol and LDL-cholesterol in the serum, showing a good effect on TNF- ⁇ derivatives can be used as a powerful anticancer drug It is an object to provide a composition.
  • the present invention provides a pharmaceutical composition
  • a pharmaceutical composition comprising a rice hull and barley husk extract as an active ingredient.
  • the extract is preferably extracted from a mixture of rice husk and barley husk in a weight ratio of 1: 0.5 to 1: 5.
  • the extract comprises 0.01 to 99.9% by weight of the composition.
  • the extract is a step of drying after dipping a mixture of rice husk and barley husk in distilled water; Adding an aqueous NaOH solution to the dried raw material and heating it; Cooling the heated raw material to separate a solution dissolved in an NaOH aqueous solution; Adding and stirring HCl solution to the separated solution; Separating the precipitate produced by the stirring to obtain a crude extract; And vacuum drying the crude extract and freeze drying to obtain a water-soluble extract and an insoluble extract.
  • the pharmaceutical composition may further include rice, oats, bean husks, and the like.
  • the pharmaceutical composition exhibits antiviral, antibacterial, anticancer, immunopotentiating and cholesterol inhibitory activity, and particularly exhibits antiviral activity against poultry, fish and livestock.
  • the pharmaceutical composition shows activity against Newcastle disease, Gamboro, poultry, poultry cholera or Marek's disease, in particular against H1N1 (H1N1) virus and H5N1 (Birdflu) virus.
  • the present invention provides a functional food composition
  • a functional food composition comprising a rice hull and barley husk extract as an active ingredient.
  • composition of the present invention is effective in the treatment and prevention of poultry, fish and livestock exposed to diseases caused by a number of pathogens, such as viruses and bacteria, and protects humans from infections caused by pathogens such as viruses, bacteria and parasites. It can maintain a healthy state and has anticancer activity.
  • pathogens such as viruses and bacteria
  • composition of the present invention has an immune enhancing effect and can be used as a cholesterol lowering agent by reducing the amount of total cholesterol and LDL-cholesterol in the serum.
  • composition of the present invention shows an excellent effect on the TNF- ⁇ derivatives can be used as a powerful anticancer agent.
  • Figure 1 shows the FT-IR, H-NMR, C-NMR spectrum of the rice husk and barley husk extract obtained according to an embodiment of the present invention.
  • Figure 2 shows the TGA, UV, DSC spectrum of the rice husk and barley husk extract obtained according to an embodiment of the present invention.
  • Figure 3 shows the LC mass by LC-MS spectroscopy of water-soluble extracts and crude extracts extracted from rice hulls and barley husks according to one embodiment of the present invention.
  • Figure 4 shows the degree of recovery over time after administering the rice husk and barley husk bark extract obtained according to an embodiment of the present invention to chickens with Newcastle disease.
  • FIG. 5 is a photograph of one day after six days after the administration of rice husk and barley husk extract obtained according to an embodiment of the present invention to chickens with Newcastle disease.
  • Figure 6 shows the degree of recovery over time after administering the rice husk and barley husk extract obtained according to an embodiment of the present invention to chickens with Gambo.
  • Figure 7 is a photograph of one day, 5 days after the administration of the rice husk and barley husk extract obtained according to an embodiment of the present invention to chickens with chicken poultry.
  • Figure 9 shows the H1N1 virus growth inhibitory activity of the rice husk and barley husk extract obtained according to an embodiment of the present invention.
  • FIG. 10 is a photograph of 7 days after 3 days of administration of rice hull and barley husk extracts obtained according to an embodiment of the present invention to the sharks infected with epidemic ulcer syndrome.
  • Figure 11 shows the activity against Vibrio bulpicus bacteria of the rice husk and barley husk extract obtained according to an embodiment of the present invention.
  • Figure 12 shows the degree of recovery over time after administering the rice husk and barley husk extract obtained according to an embodiment of the present invention to chickens infected with nasal cold.
  • Figure 13 shows the TNF- ⁇ inhibitory effect of the rice husk and barley husk extract obtained according to an embodiment of the present invention.
  • Figure 14 is to confirm whether or not infected by the rice husk and barley husk extract obtained according to an embodiment of the present invention to chicks, and then exposed to chickens infected with the disease.
  • the present inventors include a component that is resistant to viruses or acts as an antiviral agent on rice husks.
  • the present invention has been completed based on this idea, considering that the virus cannot be easily attacked even if it is not infected or infected by the virus.
  • the rice and barley described in the present invention generally mean all kinds of rice and barley grown and harvested or grown wild. Specifically, even if the varieties and production regions of rice and barley are not specified, all Of course, it means all the species of rice and barley that can be cultivated and harvested in the wild, or obtained wild, and this does not limit the scope of the present invention.
  • rice hull and barley husk extracts described below are all extracts, fractions and purified products obtained at each stage of extraction, fractionation and purification from rice hull and barley husk, diluents or concentrates thereof, dried products thereof, and the like. Of course it means all.
  • the pharmaceutical composition of the present invention comprises an extract extracted from the rice husk and barley husk as an active ingredient.
  • the rice may be used as a common rice, for example, Oryza sativa cv. Juanbyeo, Oryza sativa cv. ), Cultivated rice (Oryza sativa cv. Dongjinjubyeo-1ho) and wild rice Orissa collina (Oryza collina), Oryza alta (Oryza nie), Oriza Ostrariensis ( Oryza, including Oryza australiensis, Oryza minuta, Oryza officinalis, Oryza brachyantha and Oryza brathii Etc. can be used.
  • the use of rice varieties without genetic modification is more desirable for obtaining an effective extract.
  • the barley may also be used as a conventional barley, for example ivory barley, baekrye barley, large barley, such as shell barley, white rice barley, white glutinous rice barley, rice barley, such as sap glutinous rice barley, Jinyang barley, barley barley, ascending barley, etc. Beer barley, nutritious barley, soft barley, green barley, such as friendly barley can be used.
  • the rice husk and barley husk is mixed in a proportion, and then the extract is extracted from this mixture.
  • the extract extracted from the rice hulls and barley husks may be extracted from a mixture of rice hulls and barley husks in a weight ratio of 1:05 to 1: 5, preferably 1: 1 to 1: 3. have.
  • the mixing ratio of the rice husk and barley husk is outside the above range, the efficacy of the main ingredients in the husk husk may be hindered by barley husk ingredients, resulting in an ineffective antiviral , Antibacterial and anticancer effects are not obtained.
  • the extract of the rice husk and barley husk can be extracted by a conventional method.
  • a conventional method for example, about 1 to 15 times the volume, preferably about 5 to 10 times the amount of water, C1 to C4 lower alcohol such as ethanol, methanol or the like or a mixed solvent having a mixing ratio of about 1: 0.1 to 1:10
  • water is added and cold extraction, hot water extraction, ultrasonic extraction, reflux cooling for about 0.5 hours to 2 days, preferably 1 hour to 1 day, at an extraction temperature of 20 to 100 ° C., preferably 50 to 100 ° C.
  • Extraction, extraction of the shaker and the like is an extraction method, preferably extracted 1 to 12 times, preferably 3 to 4 times by extraction and then filtered by the extraction method of the shaker, the filtered extract is 20 to 100 °C, preferably with a vacuum rotary concentrator.
  • the residue was concentrated under reduced pressure at 40 ⁇ 70 °C dried by vacuum freeze dryer can be obtained by soluble in water, lower alcohol or a mixed solvent thereof.
  • the rice husk and barley husk extract is a step of drying after dipping a mixture of rice husk and barley husk in distilled water; Adding an aqueous NaOH solution to the dried raw material and heating it; Cooling the heated raw material to separate a solution dissolved in an NaOH aqueous solution; Adding and stirring HCl solution to the separated solution; Separating the precipitate produced by the stirring to obtain a crude extract; And vacuum drying the crude extract and freeze drying to obtain a water-soluble extract and an insoluble extract.
  • the rice husk and barley husk extract is soaked in 5L distilled water for 30 minutes on the basis of 1kg of raw material, using a pump (pump) to remove water, 15L of NaOH aqueous solution ( 0.2-1.0 N) is added and heated at reflux (80-95 ° C.) for 60-5 hours. After heating, it is cooled to 30-35 ° C. for 30-60 minutes, in which materials not dissolved in NaOH aqueous solution are precipitated at the bottom. Then, the dissolved solution is separated into a new reactor by pumping, and 1.5L HCL solution (1-2N) is quickly added to the separated solution until it reaches pH 1-2.5 and stirred for 5-10 seconds.
  • 1.5L HCL solution 1-2N
  • precipitation occurs, which causes precipitation for about 30 minutes, and clear liquids of the upper layer are removed by pumping. And the solution containing the remaining precipitate (crude extract) is filtered through a 0.45 ⁇ m membrane filter vacuum dried (about 90 °C), and then freeze-dried (freeze drying) at 10 ⁇ 20 °C dissolved part (water-soluble extract) and precipitate (Insoluble extract) is obtained. At this time, in order to obtain the active ingredient in the form of precipitates, care should be taken not to exceed 3.5.
  • the present invention has been described in the present invention a method for ideally obtaining an extract from the rice husk and barley husk, but the present invention is not limited to the method of separating the rice husk and barley husk extract. will be.
  • the rice hull and barley husk extract included in the pharmaceutical composition of the present invention can be obtained separately by a method to be improved and developed in the past or in the future.
  • Rice husk and barley husk extract extracted by the above method has a molecular weight of about 300gram / mole to 40,000gram / mole, the extract contains a monosaccharide, such as beta glucan, polysaccharides and the like.
  • Rice husk and barley husk extract contained in the pharmaceutical composition of the present invention as described above exhibits antiviral activity, antibacterial activity, anticancer activity, immune enhancing and cholesterol inhibitory effect.
  • the rice husk and barley husk extract shows antiviral activity and antibacterial activity against poultry, fish and livestock, Newcastle disease, Gaboro disease, chicken pox, poultry cholera, Marek's disease, epidemic ulcer syndrome, nasal cold Strong activity against and the like.
  • the rice husk and barley husk extract of the present invention exhibits very potent activity against H1N1 (H1N1) virus and H5N1 (Bird Flu) virus, and thus can be used as a very powerful therapeutic agent.
  • the pharmaceutical composition of the present invention comprises 0.01 to 99.9% by weight of the rice hull and barley husk extract based on the total weight of the composition.
  • the content of the extract in the composition is out of the above range, the desired degree of antiviral antibacterial and anticancer effects will not be obtained.
  • composition of the present invention may further include rice, oats, soybean hulls and the like in addition to the rice husk and barley husk extract.
  • the rice, oats, soybean hulls, etc. may be added in the form of an extract, pulverized powder, crushed granulated form, etc. according to a conventional method, of course, does not affect to obtain the desired effect in the present invention If not, the form is not limited.
  • the components are contained in 0.01 to 10% by weight relative to the rice hull and barley husk extract can further maximize the antiviral, antibacterial, anticancer activity effect of the present invention.
  • the pharmaceutical dosage forms of the rice hull and barley husk extract of the present invention may be used in the form of their pharmaceutically acceptable salts, and may also be used alone or in combination with other pharmaceutically active compounds, as well as in suitable collections. Of course it can.
  • the pharmaceutical composition comprising the rice husk and barley husk extract of the present invention comprises a pharmaceutically acceptable carrier.
  • Pharmaceutically acceptable carriers included in the pharmaceutical composition of the present invention are those commonly used in the preparation, lactose, dextrose, sucrose, sorbitol, mannitol, starch, acacia rubber, calcium phosphate, alginate, gelatin, silicic acid Calcium, microcrystalline cellulose, polyvinylpyrrolidone, cellulose, water, syrup, methyl cellulose, methyl hydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate and mineral oils, and the like. It is not.
  • the pharmaceutical composition of the present invention may further include lubricants, wetting agents, sweeteners, flavoring agents, emulsifiers, suspending agents, preservatives, etc. in addition to the above components.
  • Suitable pharmaceutically acceptable carriers and agents are described in detail in Remington's Pharmaceutical Sciences (19th ed., 1995), which can be used in pharmaceutically effective amounts.
  • pharmaceutically effective amount means an amount sufficient to achieve the above-described efficacy or activity of the active ingredient of the present invention.
  • the pharmaceutical composition of the present invention may be administered orally or parenterally, and in the case of parenteral administration, it may be administered by intravenous injection, subcutaneous injection, intramuscular injection, intraperitoneal injection, transdermal administration, mucosal administration, and eyedrop administration.
  • Suitable dosages of the pharmaceutical compositions of the present invention may be prescribed in various ways depending on factors such as the formulation method, mode of administration, age, weight, sex, morbidity, food, time of administration, route of administration, rate of excretion, reaction sensitivity, etc. of the patient. Can be. Preferably, the dosage of the pharmaceutical composition of the present invention is 0.001-100 mg / kg body weight.
  • the pharmaceutical composition of the present invention when administered to poultry, fish, and livestock, it is administered in an amount of 0.01 to 0.4 g / head for poultry, 0.01 to 0.1 g / head for fish, and 0.01 to 0.4 g / head for livestock. It is good.
  • compositions of the present invention may be prepared in unit dosage form by formulating with a pharmaceutically acceptable carrier and / or excipient, according to methods which can be easily carried out by those skilled in the art. Or by incorporating into a multi-dose container.
  • the formulation may be in the form of solutions, suspensions, syrups or emulsions in oils or aqueous media, or in the form of extracts, powders, powders, granules, tablets or capsules, and may further comprise dispersants or stabilizers.
  • the present invention also provides a food composition (or functional food composition) comprising a rice hull and barley husk extract as an active ingredient.
  • the rice husk extract and barley husk extract can be added to food as it is safe for the human body can be applied as food for the prevention and treatment of viral diseases, bacterial diseases, cancer diseases and the like. Since the food composition of this invention obtained in this way can be ingested routinely, high antiviral, antibacterial, anticancer effect can be expected, and it is very useful.
  • the rice husk and barley husk extract is included in an amount of 0.01 to 90% by weight based on the total weight of the food composition.
  • the content of the extract in the composition is out of the above range, it can express the desired antiviral, antibacterial and anticancer effects to the maximum, and have high solubility in water to form a formulation with other components.
  • the drug can be administered through a route such as oral / intravenous use.
  • the food composition is not limited in kind, but, for example, by adding a conventional palate, such as ramen, raw noodles, noodles, tofu, cereals, bread, chewing gum, candy, confectionary, etc. It can be manufactured as a food and can be applied as an edible pigment. In addition, it may be formulated into a general formulation such as tablets, granules, pills, hard capsules, soft capsules, or liquid formulations, and may also be prepared as fresh juice, pouches, beverages, or teas. In addition to the above components, other components can be appropriately selected and blended by those skilled in the art according to the formulation.
  • a conventional palate such as ramen, raw noodles, noodles, tofu, cereals, bread, chewing gum, candy, confectionary, etc. It can be manufactured as a food and can be applied as an edible pigment. In addition, it may be formulated into a general formulation such as tablets, granules, pills, hard capsules, soft capsules, or liquid formulations, and may also be prepared as fresh juice, pouch
  • the rice husk and barley husk extract included in the food composition of the present invention can effectively prevent the smell or flavor change of the food caused by oxidation, rancidity of fats and oils and discoloration of food. Therefore, the rice husk and barley husk extract of the present invention may be used for preserving these foods or maintaining the freshness and quality of foods for a long time by blending them with various conventional foods.
  • the foodstuffs are not only typical foods, but also beverages (including alcoholic beverages), fruits and processed foods (e.g. canned fruit, canned foods, jams, marmalade, etc.), fish, meat and processed foods (e.g. Hams, sausage corned beef, breads and noodles (e.g. udon, soba noodles, ramen, spagate, macaroni, etc.), fruit juices, various drinks, cookies, syrups, dairy products (e.g. butter, cheese), edible plants
  • beverages including alcoholic beverages
  • fruits and processed foods e.g. canned fruit, canned foods, jams, marmalade, etc.
  • fish e.g. Hams, sausage corned beef, breads and noodles (e.g. udon, soba noodles, ramen, spagate, macaroni, etc.)
  • fruit juices e.g. Hams, sausage corned beef, breads and noodles (e.g. udon, soba noodles, ramen, spagate, macaroni,
  • the composition of the present invention when made of a food composition, it includes not only the active ingredient of the present invention as described above, but also components commonly added in the manufacture of food, and include, for example, proteins, carbohydrates, fats, nutrients, seasonings, and Contains flavors.
  • the carbohydrates described above include monosaccharides (eg, glucose, fructose, etc.), disaccharides (eg, maltose, sucrose, oligosaccharides, etc.), polysaccharides (eg, dextrins, cyclodextrins). Or a conventional sugar such as xylitol, sorbitol, erythritol, or the like.
  • the flavoring agent natural flavoring agents (tauumatin, stevia extract (rebaudioside A, glycyrzin), etc.) and synthetic flavoring agents (saccharin, aspartame, etc.) can be used.
  • the food composition of the present invention includes various nutrients, vitamins, minerals (electrolytes), flavors such as synthetic flavors and natural flavors, coloring and neutralizing agents (such as cheese, chocolate), pectic acid and salts thereof, alginic acid and Salts, organic acids, protective colloid thickeners, pH adjusting agents, stabilizers, preservatives, glycerin, alcohols, carbonation agents used in carbonated drinks, and the like.
  • the compositions of the present invention may also contain pulp for the production of natural fruit juices and fruit juice beverages and vegetable beverages. These components can be used independently or in combination.
  • the rice hulls and barley husks were mixed in a weight ratio (w / w) of 1: 2 and mixed properly by blending.
  • 1 kg of the raw material was immersed in 5L distilled water for 30 minutes, and then water was removed using a pump.
  • 15 L of 0.2N NaOH solution was added to the wet raw material and heated at 95 ° C. for 90 minutes, and then cooled at 30 to 35 ° C. for 30 to 60 minutes. At this time, the undissolved material is settled to the bottom, the dissolved material by pumping was separated into a new reactor. 1.5L of 2N HCL solution was quickly added to the separated solution (about 12L) until pH 1-2.5 was reached and stirred for 5-10 seconds.
  • the precipitate is left to stand for 30 minutes to allow the precipitate to be generated, the clear liquid of the upper layer was removed by pumping. Then, the solution containing the remaining precipitate (about 3L, crude extract) was filtered through a 0.45 ⁇ m membrane filter and vacuum dried (about 90 °C), and then freeze dried at 10 ⁇ 20 °C (FREEZE DRYING) dissolved part ( Water soluble extract) and a precipitate (insoluble extract).
  • Example 1 Except that in Example 1, the rice husk and barley husks were mixed in a weight ratio (w / w) of 1: 1.5, 0.3N NaOH solution was added, and 2N HCl solution was added at 1.0 L. It carried out similarly to Example 1.
  • Example 1 Except that in Example 1, the rice husk and barley husks were mixed at a weight ratio (w / w) of 1: 1, 0.1N NaOH solution was added, and 0.3L of 2N HCl solution was added. It carried out similarly to Example 1.
  • Example 1 Except that in Example 1, the rice husk and barley husks were mixed at a weight ratio (w / w) of 1: 3, 0.1N NaOH solution was added, and 0.3L 2N HCl solution was added. It carried out similarly to Example 1.
  • Example 1 Except for using the rice husks and barley husks in Example 1, except that the rice husks, barley husks and rice powder mixed in a weight ratio (w / w) of 1: 2: 0.1 used in Example 1 The same procedure was followed.
  • Example 1 The brown color extract extracted in Example 1 was characterized by FT-IR, H-NMR, C-NMR, TGA, UV, DSC, LC-MS spectroscopy to observe the properties and the results are shown in FIG. . In addition, possible structures of the extracts were identified and shown in Table 1 below.
  • Table 1 below is the data obtained from the analysis by LC-MS spectroscopy, the expected structural formula of Table 1 is the structure of the extract of Example 1.
  • Figure 1 shows (a) FT-IR, (b) H-NMR, (c) C-NMR spectra, Figure 2 shows (a) TGA, (b) UV, (c) DSC spectrum, Figure 3 shows the LC mass by LC-MS spectroscopy of (a) the water-soluble extract and (b) the crude extract.
  • the brown colored extract of Example 1 was found to have about 10% solubility in demineralized water / PBS and about 90% solubility in 0.2N NaOH solution. In addition, the UV absorbance peak of the extract was found at 272 nm.
  • Example 1 The rice husks and barley husks obtained in Example 1 were treated for 8 days at a dose of 0.5 g / kg / day for 5 chickens with Newcastle disease, and then 10.5 g / s for the next two days. The dose was increased in excess of kg / day.
  • FIG. 5 is a photograph of (a) chickens with Newcastle disease (day 1), (b) chickens treated with Newcastle disease after extract administration (day 6), the rice husk and barley husk of the present invention as shown in FIG. The extract was confirmed to have an excellent therapeutic effect against poultry with Newcastle disease.
  • Chickens were infected with Gambo, and each of the 10 chickens infected with Gambo was divided into two groups of five, and one group contained the rice husk and barley husk extracts obtained in Example 1 above.
  • the dose was 0.4 g / chicken / 12 hours orally for 10 days, and the extract was not administered to the rest of the groups.
  • the rice husk and barley husk extract of the present invention has an excellent therapeutic effect against poultry affected by Gamboro disease.
  • Example 2 Five chickens with chicken poultry were treated with oral administration of the rice husk and barley husk crude extract obtained in Example 1 at 0.4 g / chicken / 12 h for 3 days, and the results were observed.
  • FIG. 7 is a photograph of (a) chicken with chicken pox (Day 1), (b) chicken treated with chicken pox (Day 5) after administration of the extract, as shown in Figure 7 the rice husk and barley husk of the present invention The extract was confirmed to have an excellent therapeutic effect against poultry caught in poultry.
  • Example 2 For 5 chickens with Marek's disease, the rice husk and barley husk crude extracts obtained in Example 1 were treated orally with 0.4 g / chicken / 12 hours for 3 days, and the results were observed. .
  • FIG. 8 is a photograph of (a) chickens with Marek's disease (day 1), (b) chickens treated with Marek's disease after administration of the extract (day 5), as shown in Figure 8 the rice husk and barley of the present invention
  • the husk extract was found to have an excellent therapeutic effect against poultry affected by Marek's disease.
  • Two-fold dilution was performed to measure the titer of virus lines (A / Beijing / H1N1 / 95) distributed by the National Institutes of Health.
  • diluted virus strain H1N1
  • 50 ⁇ l of crude extract and water-soluble extract of rice husk and barley husk obtained in Example 1 were added.
  • 50ul of PBS was put into the RBC control, and 50ul of 0.5% GP blood cells were added.
  • Virus titers were then calculated to find 4 HA Unit virus.
  • Example 1 After diluting the insoluble extract of the rice husk and barley husk obtained in Example 1 in two-fold step, and put into 25ul in V-type 96 well plate containing 5ul of viral strain (H1N1). Then, the mixture was allowed to stand at room temperature for 30 minutes, and 50 ⁇ l of 0.5% GP blood cells were put therein, followed by reading at room temperature.
  • ANABAS TESTUDINEUS (Bangladesh: KOI) infected with Pandemic Ulcer Syndrome was treated with the rice husk and barley husk extract obtained in Example 1 at a dose of 0.05 g / day for 5 days, and as a result, Was observed.
  • FIG. 10 is a photograph of a shark that is completely treated with epidemic ulcer syndrome at (a) a representative sample of idiosyncratic with ulcer syndrome, (b) 3 days after administration of extract, and (c) 7 days after administration of extract.
  • the rice husk and barley husk extract of the present invention was confirmed that the treatment effect is excellent for the fish with epidemic ulcer syndrome.
  • the rice husk and barley husk extract of the present invention was confirmed that completely inhibit the NO production, through the results of the present invention effectively inhibit the activity of the Vibrio bulpicus bacteria I could see.
  • the rice hull and barley husk extract of the present invention is excellent in the treatment effect against poultry disease caused by bacteria such as nasal cold.
  • PBMC peripheral blood monocytes
  • rat blood collected from the abdominal vein while being treated with ACD was carefully added to a tube containing 6 ml of Ficoll 1077, and the tube was then subjected to 1,500 rpm (415 G) at room temperature. Centrifuge for 30 minutes at. The cell fraction thus obtained (middle fraction) was suspended in a 50 ml tube containing phosphate buffered saline (PBS). The tube was centrifuged at 2,000 rpm (737 G) for 5 minutes.
  • ACD acid / citrate / dextrose
  • the resulting pellet was suspended in 6 ml of PBS and 6 ml of Ficoll 1077 and centrifuged at 1500 rpm (415 G) for 30 minutes at room temperature to remove residual plasma.
  • the obtained cell fractions were suspended in PBS and centrifuged for 5 minutes at 2,000 rpm. This washing process was repeated twice.
  • the recovered cells were then suspended in 10 ml RPMI-1640 containing 10% FBS and then diluted to contain 4 ⁇ 10 6 cells per ml.
  • the cell suspension was dispensed at 100 ⁇ l per well of a 96-well plate, and pretreated with 1 ⁇ l of DMSO standard solution containing placebo or the indicated concentration of the compound of the invention. The plates were incubated for 1 hour at 37 ° C.
  • Mock of FIG. 13 is a control group without any component added
  • NBML-C50 is 50 ⁇ g / ml of crude extract
  • NBML-C100 is 100 ⁇ g / ml of crude extract
  • LPS is lipopolysaccharide. It represents a substance that strongly promotes - ⁇ .
  • the rice hull and barley husk extract according to the present invention was confirmed that it can effectively lower the TNF- ⁇ level by inhibiting the production of TNF- ⁇ .
  • the rice hull and barley husk extract of the present invention can protect poultry from viral and bacterial diseases with excellent immune effect.
  • Positive Wister rats about 80-100 g in weight, were supplied by the International Center for Diarrheal Disease Research in Bangladesh.
  • the composition of the diet is beef (3 kg), starch (2.4 kg), sucrose (2.25 kg), flour (2 kg), hardened oil (1 kg), vitamin mix (10 kg), the rice pad of Example 1 Shell and barley husk extract (0%, 0.1%, 0.33%, 1% by weight) and carboxymethylcellulose (112.5 g total).
  • the cholesterol and LDL-cholesterol levels in the serum were lowered in the case of the 2-4 groups administered the rice husk and barley husk extracts according to the present invention compared to the one group without the extract. I could confirm it. In particular, it can be seen that as the concentration of the extract increases, serum cholesterol and LDL-cholesterol inhibitory effect is also improved.
  • the rice husk and barley husk extract of the present invention was found to have excellent cholesterol inhibitory effect, it could be expected that it can be used as an excellent cholesterol inhibitor.
  • the pharmaceutical composition of the present invention is effective in the treatment of fish and livestock, including a large number of poultry diseases caused by viruses, to protect humans from infection caused by pathogens such as viruses, bacteria, parasites, etc. It can be maintained as, and has anticancer activity, immune enhancing and cholesterol inhibitory effect.

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
PCT/KR2012/001263 2012-01-12 2012-02-20 Composition pharmaceutique comprenant un extrait de cortex d'oryza sativa l. et d'hordeum vulgare var. hexastichon comme principe actif Ceased WO2013105693A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020120003830A KR101363111B1 (ko) 2012-01-12 2012-01-12 벼 겉껍질 및 보리 겉껍질 추출물을 유효성분으로 포함하는 약학 조성물
KR10-2012-0003830 2012-01-12

Publications (1)

Publication Number Publication Date
WO2013105693A1 true WO2013105693A1 (fr) 2013-07-18

Family

ID=48781626

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2012/001263 Ceased WO2013105693A1 (fr) 2012-01-12 2012-02-20 Composition pharmaceutique comprenant un extrait de cortex d'oryza sativa l. et d'hordeum vulgare var. hexastichon comme principe actif

Country Status (2)

Country Link
KR (1) KR101363111B1 (fr)
WO (1) WO2013105693A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103638115A (zh) * 2013-12-05 2014-03-19 李德权 防治禽流感纯中药粉
CN104208300A (zh) * 2014-08-19 2014-12-17 广西博士海意信息科技有限公司 治疗鼻炎的中药
CN104547292A (zh) * 2014-12-17 2015-04-29 蒋树侠 一种治疗慢性鼻炎的复方药物

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102275552B1 (ko) * 2014-12-31 2021-07-09 (주)아모레퍼시픽 유색 보리 추출물을 포함하는 체취 억제용 조성물
KR102210919B1 (ko) * 2019-07-02 2021-02-02 한국식품연구원 보리잎 유래 다당 분획물을 유효성분으로 함유하는 인플루엔자 바이러스 감염 질환의 개선, 예방 또는 치료용 조성물
KR102231437B1 (ko) * 2020-09-21 2021-03-24 주식회사 보삼바이오산업 고병원성 조류 인플루엔자 바이러스 감염의 예방 또는 치료용 조성물의 제조방법 및 그를 이용하여 제조한 고병원성 조류 인플루엔자 바이러스 감염의 예방 또는 치료용 조성물
KR102608555B1 (ko) * 2020-12-10 2023-12-04 한국기초과학지원연구원 살바이러스 조성물 및 그 제조방법

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000102353A (ja) * 1998-09-29 2000-04-11 Hiroshi Kurino 米を精米した後に残るもみがらを粉砕して 家畜等の飼料として再利用する方法
KR20040101728A (ko) * 2003-05-26 2004-12-03 학교법인 한마학원 천연 항산화용 왕겨 추출물의 제조 및 그 이용방법
KR20070000004A (ko) * 2005-06-24 2007-01-02 김무겸 가공된 왕겨 조성물의 제조방법
KR100836568B1 (ko) * 2006-05-09 2008-06-10 경남대학교 산학협력단 왕겨 추출물을 유효성분으로 함유하는 항암용 조성물

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000102353A (ja) * 1998-09-29 2000-04-11 Hiroshi Kurino 米を精米した後に残るもみがらを粉砕して 家畜等の飼料として再利用する方法
KR20040101728A (ko) * 2003-05-26 2004-12-03 학교법인 한마학원 천연 항산화용 왕겨 추출물의 제조 및 그 이용방법
KR20070000004A (ko) * 2005-06-24 2007-01-02 김무겸 가공된 왕겨 조성물의 제조방법
KR100836568B1 (ko) * 2006-05-09 2008-06-10 경남대학교 산학협력단 왕겨 추출물을 유효성분으로 함유하는 항암용 조성물

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
HO MOON, SEOG ET AL.: "Characteristics of Barley Polyphenol Extract (BPE) Separated from Pearling By-products", KOREAN JOURNAL OF FOOD SCIENCE AND TECHNOLOGY, vol. 34, no. 5, 2002, pages 775 - 779, XP053023659 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103638115A (zh) * 2013-12-05 2014-03-19 李德权 防治禽流感纯中药粉
CN104208300A (zh) * 2014-08-19 2014-12-17 广西博士海意信息科技有限公司 治疗鼻炎的中药
CN104547292A (zh) * 2014-12-17 2015-04-29 蒋树侠 一种治疗慢性鼻炎的复方药物

Also Published As

Publication number Publication date
KR20130083194A (ko) 2013-07-22
KR101363111B1 (ko) 2014-02-14

Similar Documents

Publication Publication Date Title
KR101363111B1 (ko) 벼 겉껍질 및 보리 겉껍질 추출물을 유효성분으로 포함하는 약학 조성물
WO2020235929A1 (fr) Composition pour augmenter la biodisponibilité et favoriser l'absorption de ginsénosides dans un extrait de ginseng noir
WO2010140734A1 (fr) Composition, pour la prévention ou le traitement d'affections liées à l'obésité et médiées par l'activation d'ampk, et dont les principes actifs dont des lignanes de 2,5-bis-aryl-3,4-diméthyltétrahydrofurane
WO2020091265A1 (fr) Composition comprenant un extrait de sureau comme composant actif pour prévenir ou traiter le syndrome climatérique masculin ou réduire ses symptômes
WO2016153211A2 (fr) Procédé de préparation d'extrait d'écorce d"agrumes et composition pour prévenir, soulager ou traiter une lésion hépatique
WO2015002391A1 (fr) Composition présentant une fonction d'atténuation du syndrome prémenstruel et des douleurs menstruelles
WO2024005561A1 (fr) Composition comprenant un extrait de stewartia pseudocamellia en tant que principe actif pour la prévention ou le traitement de la démence
WO2013062247A2 (fr) Composé diterpène de type phorbol, et composition pharmaceutique pour le traitement ou la prévention de maladies infectieuses virales le comprenant
WO2016190566A2 (fr) Composition pharmaceutique ou aliment naturel fonctionnel pour la prévention et le traitement de maladies métaboliques, contenant un extrait aqueux de pleurotus eryngii var. ferulae (pf.) en tant que principe actif
JP2025122663A (ja) 肉桂抽出物、前記抽出物の分画物または分離物、またはこれから分離された化合物を含む胃炎または消化性潰瘍の予防、改善または治療用組成物
WO2018080157A1 (fr) Composition pour la prévention, le soulagement ou le traitement d'un déficit cognitif, contenant un extrait de ficus erecta en tant que principe actif
WO2018190501A1 (fr) Composition anti-inflammatoire contenant un extrait de pédoncule de fleur de ginseng
KR20180082921A (ko) 위염 또는 소화성궤양 예방 또는 치료용 조성물
WO2025009748A1 (fr) Composition antioxydante et anti-inflammatoire comprenant un extrait de feuille de carotte à l'eau de mer volcanique en tant que principe actif
KR20210087771A (ko) 어성초 추출물 또는 이로부터 분리한 화합물을 유효성분으로 하는 치매의 예방 또는 치료용 조성물
WO2024117525A1 (fr) Hydrolysat de protéine de larves de mouche soldat noire et son procédé de production
WO2023249392A1 (fr) Composition pour la prévention, l'atténuation ou le traitement d'une infection à coronavirus, contenant un extrait d'herbe médicinale utilisé en tant que principe actif
WO2017175915A1 (fr) Nouveau composé isolé à partir de tenebrio molitor et procédé pour son isolement
KR20160143628A (ko) 커큐미노이드계 화합물, 및 감초 추출물 또는 이의 분획물을 포함하는 인플루엔자 바이러스 감염의 예방 또는 치료용 조성물
WO2015122728A1 (fr) Composition anti-tuberculose pour le traitement et la prévention de la tuberculose comprenant un extrait ou de melia azedarach l. ou un extrait de lobelia chinensis lour et des fractions de ceux-ci
KR20160090662A (ko) 쥐눈이콩 추출물을 포함하는 망막질환의 예방 또는 치료용 조성물
KR101688116B1 (ko) 여주 추출물을 유효성분으로 포함하는 남성 갱년기 치료 및 예방용 조성물
KR20150086928A (ko) 커큐미노이드계 화합물, 및 감초 추출물 또는 이의 분획물을 포함하는 인플루엔자 바이러스 감염의 예방 또는 치료용 조성물
WO2014163262A1 (fr) Composition pour traiter ou prévenir l'obésité, contenant de l'extrait de graines de piment
WO2023048504A1 (fr) Composition pour prévenir ou traiter des maladies associées à une faiblesse musculaire ou une sarcopénie, contenant un extrait de rosa davurica pallas en tant que principe actif

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12865213

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12865213

Country of ref document: EP

Kind code of ref document: A1